Home Cart Sign in  
Chemical Structure| 872573-93-8 Chemical Structure| 872573-93-8

Structure of RO-3306
CAS No.: 872573-93-8

Chemical Structure| 872573-93-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ro 3306 is a potent and selective inhibitor of CDK1 with Ki value of 35 nM for CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and > 50-fold relative to CDK4/cyclin D.

Synonyms: Ro-3306

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of RO-3306

CAS No. :872573-93-8
Formula : C18H13N3OS2
M.W : 351.45
SMILES Code : O=C1N=C(NCC2=CC=CS2)S/C1=C/C3=CC=C4N=CC=CC4=C3
Synonyms :
Ro-3306
MDL No. :MFCD17392573
InChI Key :XOLMRFUGOINFDQ-YBEGLDIGSA-N
Pubchem ID :135400873

Safety of RO-3306

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of RO-3306

Hedgehog

Isoform Comparison

Biological Activity

Target
  • CDK1

    CDK1, Ki:20 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 5 µM 15 min RO-3306 treatment induced dephosphorylation of Gwl at S90 and S453 sites and caused a downshift in Gwl migration band, indicating that RO-3306 promoted Gwl dephosphorylation by inhibiting Cdk1 activity. Elife. 2015 Dec 14;4:e10399.
HeLa cells 9 µM 20 h Used to synchronize cell divisions and fix cells at metaphase for subsequent experiments. Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2120536120.
RPE1 cells 7.5 μM 18 h Synchronize RPE1 cells into G2 phase and arrest them in G2 phase by RO3306 treatment for subsequent cell cycle time course experiments. Mol Cell Proteomics. 2020 Sep;19(9):1450-1467.
HeLa cells 10 µM 12 h To study the effect of RO-3306 on HeLa cells synchronized at the G2/M border, results showed that RO-3306 inhibited Cdk1 activity and delayed mitotic entry. Sci Adv. 2018 Jun 6;4(6):eaap7777.
Glioma stem cells (GSCs) 20 μM 12 h Inhibits CDK1 activity, reduces serine phosphorylation of Ubc9, thereby attenuating the interaction between Pin1 and Ubc9. Nat Commun. 2024 Jan 2;15(1):40.
muscle satellite cells 0.5 μM 24 h Inhibit Cdk1/Ccnb1 activity, reduce BrdU incorporation in FoxM1-overexpressing muscle satellite cells Cell Death Dis. 2020 Mar 9;11(3):180.
HT1376 and HT1197 BC cells 20 μM 2 h RO-3306 increased the expression of ID2, indicating that CDK1 inhibition can enhance ID2 expression. Exp Mol Med. 2022 Jun;54(6):801-811.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Orthotopic GBM xenografts Intraperitoneal injection 20 mg/kg Every other day until the end of the experiments Inhibits CDK1 activity, reduces SUMO1-modified protein sumoylation, suppresses tumor growth, and extends mouse survival. Nat Commun. 2024 Jan 2;15(1):40.
Mice FoxM1-overexpressing mice Intraperitoneal injection 4 mg/kg 4 times per week for 5 weeks Inhibit Cdk1/Ccnb1 activity, restore the muscle satellite cell pool in FoxM1-overexpressing mice Cell Death Dis. 2020 Mar 9;11(3):180.
NSG immunodeficient mice Orthotopic BC xenograft model Intraperitoneal injection 4 mg/kg Every 4 days, 6 times RO-3306 monotherapy inhibited 33.2% of tumor growth, and combination with apigenin inhibited 63.1% of tumor growth, indicating that RO-3306 enhanced the antitumor effect of apigenin. Exp Mol Med. 2022 Jun;54(6):801-811.
Nude mice Breast cancer xenograft model Intraperitoneal injection 4 mg/kg Every 2 days until sacrifice To examine the effect of CDK1 inhibitor RO-3306 on tumor growth, results showed that RO-3306 significantly inhibited tumor growth. Adv Sci (Weinh). 2023 Apr;10(11):e2205873.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.28mL

14.23mL

2.85mL

1.42mL

28.45mL

5.69mL

2.85mL

References

 

Historical Records

Categories